Description:
GYRATE ATROPHY OF CHOROID AND RETINA; GACR
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Disorders of the Urea Cycle |
Class |
Disorders of Amino Acid Metabolism |
Cell Type
|
Fibroblast
|
Transformant
|
Untransformed
|
Race
|
White
|
Family Member
|
2
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
Passage Frozen |
17 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase, Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
|
GENE MAPPING & DOSAGE STUDIES - Y CHROMOSOME |
PCR analysis of DNA from this cell culture gave a negative result with a primer for Yq11, DYS227. |
|
ornithine aminotransferase |
According to the submitter, biochemical test results for this subject showed decreased enzyme activity. EC Number: 2.6.1.13; 6% activity. |
|
Remarks |
Pyridoxine responsive; approximately 6% of control fibroblast ornithine aminotransferase activity; not of Finnish extraction; marked myopia; abnormal electroretinography & electro-oculography; similarly affected sister |
Wirtz MK, Kennaway NG, Weleber RG, Heterogeneity and complementation analysis of fibroblasts from vitamin B6 responsive and non-responsive patients with gyrate atrophy of the choroid and retina. J Inherit Metab Dis8:71-4 1985 |
PubMed ID: 3939534 |
|
Weleber RG, Wirtz MK, Kennaway NG, Gyrate atrophy of the choroid and retina: clinical and biochemical heterogeneity and response to vitamin B6. Birth Defects Orig Artic Ser18:219-30 1982 |
PubMed ID: 7171757 |
|
Weleber RG, Kennaway NG, Clinical trial of vitamin B6 for gyrate atrophy of the choroid and retina. Ophthalmology88:316-24 1981 |
PubMed ID: 6789268 |
|
Kennaway NG, Weleber RG, Buist NR, Gyrate atrophy of the choroid and retina with hyperornithinemia: biochemical and histologic studies and response to vitamin B6. Am J Hum Genet32:529-41 1980 |
PubMed ID: 7395865 |
Passage Frozen |
17 |
Split Ratio |
1:2 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Substrate |
None specified |
Subcultivation Method |
trypsin-EDTA |
Supplement |
- |
|
|